Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.

You are here:Home-Chemical Inhibitors & Agonists-Cell Cycle/DNA Damage-Monopolar Spindle 1 (Mps1/TTK)-Mps1-IN-3
Mps1-IN-3

Chemical Structure : Mps1-IN-3

CAS No.: 1609584-72-6

Mps1-IN-3 (MPS1 inhibitor 3)

Catalog No.: PC-43017Not For Human Use, Lab Use Only.

Mps1-IN-3 is a selective and highly potent Mps1 kinase inhibitor with IC50 of 50 nM.

Packing Price Stock Quantity
10 mg $98 In stock
25 mg $158 In stock
50 mg $258 In stock
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

Mps1-IN-3 is a selective and highly potent Mps1 kinase inhibitor with IC50 of 50 nM.
Mps1-IN-3 causes mitotic aberrancies in glioblastoma cells and, in combination with vincristine, induces mitotic checkpoint override, increases aneuploidy and augmentes cell death.
Mps1-IN-3 sensitizes glioblastoma cells to vincristine in orthotopic mouse models, resulting in prolonged survival without toxicity.

Physicochemical Properties

M.Wt 537.6339
Formula C26H31N7O4S
Appearance Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

4-Piperidinol, 1-[3-methoxy-4-[[6-[[2-[(1-methylethyl)sulfonyl]phenyl]amino]-9H-purin-2-yl]amino]phenyl]-

References

1. Tannous BA, et al. J Natl Cancer Inst. 2013 Sep 4;105(17):1322-31.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: